header bar
  MyelomaLinks - Your Link to the Latest Myeloma News  


NOVEMBER 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to MyelomaLinks, your monthly source of myeloma news, research updates, clinical trials and events of The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Myeloma News

Low-dose dexamethasone superior to high-dose for myeloma; trial stopped early
In patients with newly diagnosed multiple myeloma, combining the thalidomide analog lenalidomide with low-dose dexamethasone led to better short-term survival than lenalidomide plus high-dose dexamethasone, along with fewer serious side effects

::READ MORE NEWS::
LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month  
:: READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. LLS's LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own.

Here to Help

For even more information, regularly visit the LLS Web site,
www.LLS.org, where many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in MyelomaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

Please consider a tax-deductible gift to LLS. Donate online today and help us make a difference in the lives of patients and their families. 

 

Researcher Image

Commentary
Deborah Banker, Ph.D., shares exciting advances in stem cell transplantation.

Clinical Trials
We invite you to use our LLS-supported TrialCheck® Web site , a clinical trial search service that offers patients and caregivers immediate access to listings of all myeloma clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy-to-read list of search results.
::SEE CLINICAL TRIALS::

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute.



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
::CLICK HERE TO SIGN UP::


bottom bar

Latest Myeloma News
news image

Balloon kyphoplasty effective for malignant spinal fractures
Balloon kyphoplasty provides pain relief and functional improvement in patients with malignant spinal fractures, say researchers. Balloon kyphoplasty is performed percutaneously in an effort to relieve pain, restore vertebral height, and reduce biomechanical alterations of the spine caused by fractures, the authors explain.

Lenalidomide/bortezomib safe, promising against relapsed multiple myeloma
The combination of the immunomodulatory drug lenalidomide and the proteasome inhibitor bortezomib appears to be both safe and potentially able to induce durable responses in patients with relapsed or relapsed/refractory multiple myeloma, U.S. researchers report online in the Journal of Clinical Oncology.

> Back to the top

LLS Features

calendar image

Archived Educational Events
Experience archived Myeloma teleconferences and Webcasts free of charge, anytime. Also, the opportunity to download the audio file, read the written transcript or listen online to the recent program Managing Myeloma: An Expert's Update are now available on the LLS Web site.

Online Support Groups 
Enroll in new Online Support Groups: free, password protected weekly groups led by trained professionals for adults living with leukemia, lymphoma, myeloma and myelodysplastic syndromes and their caregivers.  Through these groups, we invite you to receive and share support, feedback and information with other people living with blood cancers and their loved ones.
 
Financial Health Matters 
This new internet webcast for patients, family members and healthcare professionals, focuses on the financial impact a cancer diagnosis can have and the various insurance programs and resources available for information and support.  View the webcast or print/read the program transcript and slides of this program.

Co-Pay Assistance Program
Patients with myeloma who have difficulty paying for or simply cannot afford their prescription drug co-pays or health insurance premiums can now apply for up to $5,000 in assistance from LLS. 

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard.

Act Now! - Urge Congress to Improve Comprehensive Cancer Care 

Free Materials
New detailed and basic publications are now available in English and Spanish. To view and order, see Myeloma, The Myeloma Guide, Pain Management Mieloma, La guía sobre el mieloma and Manejo del dolor.

We'd Like to Hear from You!
Please give us your feedback after you read an LLS Publication by completing our evaluation:
LLS Disease & Treatment Publications - Survey for Patients, Family and Friends

Nos gustaría saber sus opiniones
Por favor denos sus comentarios después de leer una publicación de LLS completando nuestra evaluación:
Publicaciones de LLS sobre enfermedades y tratamiento: Encuesta para pacientes, familiares y amigos

LLS Blog


The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families.
Learn the many ways you can help advance LLS's mission. 

> Back to the top

Research Roundup

links_image_micro2

Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. ::READ MORE::

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. ::READ MORE::

Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204). ::READ MORE::

Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma. ::READ MORE::

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. ::READ MORE::

> Back to the top
Clinical Trials

Clinical Trials Image

Lenalidomide, Thalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma ::READ MORE::

Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma ::READ MORE::

Phase III Study to Determine Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone versus Melphalan, Prednisone, Thalidomide in Patients with Previously Untreated Multiple Myeloma (FIRST) ::READ MORE::

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant ::READ MORE::

> Back to the top
IRC Question of the Month
Q&A

Q: How can I be an active participant in my care?

A: You can play a vital role in your wellbeing by being involved in your own care. Participating can help you understand how your disease is being managed, make informed decisions and feel more in control of your life.

5 Important Steps for Participating in Your Healthcare

1. Learn all you can about your diagnosis.

  • Know your specific disease type, stage of disease and what all of your potential treatment options are, including treatments in clinical trials.

2. Get the most from your meetings with your doctor and other members of your healthcare team.

  • Prepare ahead of your medical appointments. Bring a list of questions and concerns with you. Maintain a list in between appointments so you can record questions and concerns as they arise. Be assertive. Ask questions until you receive a complete explanation. If your doctor provides information that is too technical or limited in scope, ask that he/she provide you with information that is more patient-friendly. Take notes or tape record the session so you can easily recall and review the responses at a later time. If possible, bring someone with you to appointments to take notes and be a second "pair of ears."

3. Follow medical advice.

  • Keep all medical appointments. Take at-home medications as instructed. Following instructions for preventing infections. Maintain healthy diet, exercise and sleep habits.

4. Keep a file with copies of your medical records and other diagnostic and treatment information.

  • Keep copies of your medical history, your test results and the medications used to treat you. Include you started and stopped medications, any side effects, a list of medications you take for other health reasons, such as blood pressure medication. Keeping copies and/or recording key information will enable you to refer it for discussions with members of your healthcare team.

5. Seek support and network with other people who have your diagnosis.

  • This is an excellent way to learn more about the disease, what to expect from treatment, share common concerns and gain support.

To help you advocate for yourself, LLS offers you

  • Educational materials that provide this helpful information regarding blood cancers. Click here for free Disease, Treatment and Support booklets and fact sheet.

  • A clinical trial service using an easy search tool and/or our Information Specialists. In fact, if you have any questions about leukemia, lymphoma or myeloma give our information specialists a call at 1-800-955-4572 or contact us online. We're available Monday through Friday from 9 a.m. to 6 p.m. ET.

  • Free live telephone and Web-based education programs that feature disease experts who present information about the latest on disease research and treatment. If you are unable to take part the day of the program, an audio and written transcript on saved our Web site. Click here for more information. To be notified by email of our upcoming programs you may register, for email alerts, on our homepage ( www.LLS.org).

  • Support services all over the United States and Canada to meet the needs of patients, caregivers and families. Please contact your local chapter office to learn more and become active. To identify your local chapter, input your Zip or Postal Code in the Chapter Finder tool on our homepage (www.LLS.org).

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.

> Back to the top

Supported by an unrestricted
educational grant from
Allos Therapeutics, Inc Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.